According to the research report titled ‘North America Automated Breast Ultrasound Systems (ABUS) Market Size By Product, End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024’, available with Market Study Report, North America automated breast ultrasound (ABUS) market is expected to surpass USD 464 million by the year 2024.
 

Increased pervasiveness of breast cancer in Canada and U.S. is a prime factor fostering the automated breast ultrasound systems market growth in North America. Low efficiency of mammography while diagnosing women with dense breast tissue will also drive the market growth. However, high costs associated with automated breast imaging systems may restrain the market expansion.
 

By product type, ABVS (automated breast volume scanners) segment is slated to witness a growth rate of 16.6% during 2018-2024. The device captures high resolution images of dense breasts which further helps in early diagnosis of breast cancer.
 

Citing the end-use landscape, North America ABUS market from diagnostic imaging centers segment was worth USD 66 million in 2017 and is expected to grow significantly during the forecast period. High concentration of established diagnostic imaging centers which offer superior quality care to patients is fueling the segmental growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2505944/
 

As per regional analysis, Canada automated breast ultrasound systems industry is presumed to expand with a CAGR of 26% through 2024. Rising prevalence of breast cancer and favorable government initiatives towards increasing awareness regarding early diagnosis is propelling the adoption of automated breast ultrasound systems in Canada.
 

The prominent companies functioning in North America automated breast ultrasound systems industry are SonoCine Inc., Siemens AG, Hitachi Ltd., Koninjklijke Philips N.V., and GE Healthcare.